Published in Brain Res on June 15, 2010
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med (2015) 1.61
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging (2012) 1.32
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease. J Alzheimers Dis (2012) 1.03
Sleep disturbances in Alzheimer's and Parkinson's diseases. Neuromolecular Med (2012) 1.00
3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress. Neurobiol Aging (2011) 0.98
DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One (2011) 0.98
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease. Alzheimers Res Ther (2013) 0.97
A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol (2012) 0.91
Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease. Front Cell Neurosci (2015) 0.90
A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease. PLoS One (2013) 0.90
Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease. J Alzheimers Dis (2015) 0.88
The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice. Neuropharmacology (2015) 0.86
Central CRF system perturbation in an Alzheimer's disease knockin mouse model. Neurobiol Aging (2012) 0.85
Synchronization of Biological Clock Neurons by Light and Peripheral Feedback Systems Promotes Circadian Rhythms and Health. Front Neurol (2015) 0.85
A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease. Front Pharmacol (2013) 0.84
Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J Alzheimers Dis (2014) 0.83
Rodent models for Alzheimer's disease drug discovery. Expert Opin Drug Discov (2015) 0.82
B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments. Brain Behav (2013) 0.81
Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One (2012) 0.81
Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis. Biochim Biophys Acta (2013) 0.81
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease. Int J Neuropsychopharmacol (2014) 0.81
Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer's Disease. Int J Mol Sci (2016) 0.79
Age-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice. Front Aging Neurosci (2014) 0.78
An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk. PLoS One (2013) 0.77
Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models. Mol Cell Neurosci (2014) 0.77
PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Aβ. J Neurosci (2013) 0.77
Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport. PLoS One (2016) 0.77
Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model. Sci Rep (2015) 0.76
Deficits in memory-guided limb movements impair obstacle avoidance locomotion in Alzheimer's disease mouse model. Sci Rep (2014) 0.75
Neuroprotective Effects of the Herbal Formula B401 in Both Cell and Mouse Models of Alzheimer's Disease. Evid Based Complement Alternat Med (2016) 0.75
Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function. Neural Plast (2016) 0.75
Physiological links of circadian clock and biological clock of aging. Protein Cell (2017) 0.75
Protective Effects of Wogonin against Alzheimer's Disease by Inhibition of Amyloidogenic Pathway. Evid Based Complement Alternat Med (2017) 0.75
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci (2006) 2.32
Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2007) 2.08
Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem (2007) 1.43
Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci U S A (2006) 1.26
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res (2010) 1.24
Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res (2006) 1.23
Temporal and spatial expression patterns of canonical clock genes and clock-controlled genes in the suprachiasmatic nucleus. Eur J Neurosci (2004) 1.22
Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem (2007) 1.19
Zinc and cortical plasticity. Brain Res Rev (2008) 1.18
Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol (2014) 1.18
Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis (2011) 1.13
Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol (2010) 1.13
Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol (2011) 1.07
The role of zinc in cerebral ischemia. Mol Med (2007) 1.05
Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease. J Proteomics (2011) 1.03
Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem (2009) 1.03
Amplitude of the SCN clock enhanced by the behavioral activity rhythm. PLoS One (2012) 0.99
Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model. Alzheimers Dement (2011) 0.97
Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis (2010) 0.96
Nonserotonergic projection neurons in the midbrain raphe nuclei contain the vesicular glutamate transporter VGLUT3. Synapse (2009) 0.95
Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J Immunol (2007) 0.93
Distribution of zincergic neurons in the mouse forebrain. J Comp Neurol (2004) 0.93
Modeling the behavior of coupled cellular circadian oscillators in the suprachiasmatic nucleus. J Biol Rhythms (2007) 0.91
Inhaled anesthetic potency in aged Alzheimer mice. Anesth Analg (2009) 0.91
Entrainment of circadian clocks in mammals by arousal and food. Essays Biochem (2011) 0.90
BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology. Neurotox Res (2011) 0.90
Circadian clock resetting by sleep deprivation without exercise in Syrian hamsters: dark pulses revisited. J Biol Rhythms (2002) 0.88
Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions. Curr Pharm Des (2012) 0.88
Cloning and cortical expression of rat Emx2 and adenovirus-mediated overexpression to assess its regulation of area-specific targeting of thalamocortical axons. Cereb Cortex (2003) 0.87
Presenilin-null cells have altered two-pore calcium channel expression and lysosomal calcium: implications for lysosomal function. Brain Res (2012) 0.86
The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwDI mice. Am J Pathol (2013) 0.86
Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration. Eur J Neurosci (2007) 0.86
13-Desmethyl spirolide-C is neuroprotective and reduces intracellular Aβ and hyperphosphorylated tau in vitro. Neurochem Int (2011) 0.86
The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta. J Neurochem (2004) 0.85
ST101 induces a novel 17 kDa APP cleavage that precludes Aβ generation in vivo. Ann Neurol (2011) 0.84
Object/context specific memory deficits following medial frontal cortex damage in mice. PLoS One (2012) 0.84
Induction of reproducible focal ischemic lesions in neonatal mice by photothrombosis. Dev Neurosci (2005) 0.84
Disrupted tonotopy of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptor. Hear Res (2005) 0.84
Phenotype and function of raphe projections to the suprachiasmatic nucleus. Eur J Neurosci (2010) 0.84
Retrograde tracing of the subset of afferent connections in mouse barrel cortex provided by zincergic neurons. J Comp Neurol (2005) 0.83
The cholinergic antagonist gymnodimine improves Aβ and tau neuropathology in an in vitro model of Alzheimer disease. Cell Physiol Biochem (2011) 0.83
Differential progression of magnetization transfer imaging changes depending on severity of cerebral hypoxic-ischemic injury. J Cereb Blood Flow Metab (2008) 0.82
I-CAN SLEEP: rationale and design of a non-inferiority RCT of Mindfulness-based Stress Reduction and Cognitive Behavioral Therapy for the treatment of Insomnia in CANcer survivors. Contemp Clin Trials (2011) 0.82
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice. Neurobiol Aging (2008) 0.82
Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways. Life Sci (2012) 0.82
The role of Period1 in non-photic resetting of the hamster circadian pacemaker in the suprachiasmatic nucleus. Neurosci Lett (2004) 0.82
Developmental distribution of calretinin in mouse barrel cortex. Brain Res Dev Brain Res (2003) 0.80
Long-term outcomes of developmental exposure to fluoxetine: a review of the animal literature. Dev Neurosci (2013) 0.79
Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice. PLoS One (2012) 0.79
High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats. Exp Neurol (2011) 0.79
The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse. Psychopharmacology (Berl) (2012) 0.79
Early increases in soluble amyloid-β levels coincide with cholinergic degeneration in 3xTg-AD mice. J Alzheimers Dis (2012) 0.78
Relationship between membrane potential oscillations and rhythmic discharges in identified hippocampal theta-related cells. J Neurophysiol (2002) 0.78
Rapid, experience-dependent changes in levels of synaptic zinc in primary somatosensory cortex of the adult mouse. J Neurosci (2002) 0.78
Larger cortical motor maps after seizures. Eur J Neurosci (2011) 0.78
Novel, whisker-dependent texture discrimination task for mice. Behav Brain Res (2012) 0.78
Reduction of the immunostainable length of the hippocampal dentate granule cells' primary cilia in 3xAD-transgenic mice producing human Aβ(1-42) and tau. Biochem Biophys Res Commun (2012) 0.78
Parent and family impact of raising a child with perinatal stroke. BMC Pediatr (2014) 0.78
A single generalized seizure alters the amplitude, but not phase, of the circadian activity rhythm of the hamster. Chronobiol Int (2009) 0.77
Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism. Exp Neurol (2009) 0.77
Lesion size and behavioral deficits after endothelin-1-induced ischemia are not dependent on time of day. J Stroke Cerebrovasc Dis (2011) 0.77
Neonatal medial frontal cortex lesions disrupt circadian activity patterns. Dev Neurosci (2009) 0.77
Enhanced plasticity in zincergic, cortical circuits after exposure to enriched environments. J Neurosci (2008) 0.76
Bi-parental care contributes to sexually dimorphic neural cell genesis in the adult mammalian brain. PLoS One (2013) 0.76
Serotonin 1A receptors alter expression of movement representations. J Neurosci (2013) 0.76
The serotonergic anxiolytic buspirone attenuates circadian responses to light. Eur J Neurosci (2014) 0.76
An improved method for visualizing the cell bodies of zincergic neurons. J Neurosci Methods (2003) 0.76
Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life. Dev Neurosci (2014) 0.76
MAO(A) knockout mice are more susceptible to seizures but show reduced epileptogenesis. Epilepsy Res (2004) 0.75
COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model. J Neurochem (2015) 0.75
The serotonergic anxiolytic buspirone attenuates circadian responses to light. Eur J Neurosci (2016) 0.75
Altered zincergic innervation of the developing primary somatosensory cortex in monoamine oxidase-A knockout mice. Brain Res Dev Brain Res (2003) 0.75
Alterations in protein and gene expression within the barrel cortices of ZnT3 knockout mice: experience-independent and dependent changes. Neurochem Int (2011) 0.75
Investigating the role of substance P in photic responses of the circadian system: individual and combined actions with gastrin-releasing peptide. Neuropharmacology (2009) 0.75
Erratum: Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents. Nat Med (2017) 0.75
Temporal changes of light-induced proteins in the SCN following treatment with the serotonin mixed agonist/antagonist BMY7378. Exp Brain Res (2015) 0.75
The enigma of behavioral inputs to the circadian clock: a test of function using restraint. Physiol Behav (2006) 0.75
Proflavine derivatives as fluorescent imaging agents of amyloid deposits. Bioorg Med Chem Lett (2011) 0.75